Discontinued — last reported Q3 '23
Roper Technologies, Inc. Equity Method Investments increased by 21.0% to $963.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 32.3%, from $728.20M to $963.60M.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $535.00M | $535.00M | $591.30M | $736.40M | $795.70M | $852.50M | $842.80M | $878.60M | $772.30M | $728.20M | $739.70M | $756.00M | $796.30M | $963.60M |
| QoQ Change | — | — | +0.0% | +10.5% | +24.5% | +8.1% | +7.1% | -1.1% | +4.2% | -12.1% | -5.7% | +1.6% | +2.2% | +5.3% | +21.0% |
| YoY Change | — | — | — | — | — | +48.7% | +59.3% | +42.5% | +19.3% | -2.9% | -14.6% | -12.2% | -14.0% | +3.1% | +32.3% |